In this interview we discuss the role of checkpoint inhibitors in advanced lung cancer and treatment strategies when patients progress.
Oncology Vol 31 No 6
In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Cytoreductive Surgery Is the Best Way to Affect Survival Outcomes
Advertisement
Advertisement
Trending on CancerNetwork
1
More Global Expertise and Talent Are Needed to Administer Cell Therapies
2
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
3
Adaptive Treatment and Other Advances May Drive Radiotherapy Field Forward
4
Region-Based Genetic Disorders Affect Cancer Treatment Decisions
5
